AAAAAA
Results:
1-22
|
Results: 22
Authors:
KINDER M
GOMMER E
JANKNEGT R
VANDOORN EV
Citation: M. Kinder et al., RECORDING THE DETRUSOR ELECTROMYOGRAM IS STILL A DIFFICULT AND CONTROVERSIAL ENTERPRISE, Neurourol. urodyn., 17(5), 1998, pp. 571-573
Authors:
JANKNEGT R
Citation: R. Janknegt, THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH SPECIAL REFERENCE TO PHARMACOKINETIC, PHARMACODYNAMIC AND PHARMACOECONOMIC CONSIDERATIONS, Pharmacy world & science, 19(3), 1997, pp. 133-141
Authors:
HEESAKKERS J
WEN JG
DEBRUINE A
VANDENBOGAARD A
JANKNEGT R
Citation: J. Heesakkers et al., DYNAMIC URINARY GRACILOPLASTY IN MALE GOATS - A STUDY ON HISTOLOGY AND URETHRAL PRESSURES, Neurourol. urodyn., 16(2), 1997, pp. 117-123
Authors:
JANKNEGT R
STEENHOEK A
Citation: R. Janknegt et A. Steenhoek, THE SYSTEM OF OBJECTIFIED JUDGMENT ANALYSIS (SOJA) - A TOOL IN RATIONAL DRUG SELECTION FOR FORMULARY INCLUSION, Drugs, 53(4), 1997, pp. 550-562
Authors:
JANKNEGT R
VANDERKUY A
DECLERCK G
IDZIKOWSKI C
Citation: R. Janknegt et al., HYPNOTICS - DRUG SELECTION BY MEANS OF THE SYSTEM OF OBJECTIFIED JUDGMENT ANALYSIS (SOJA) METHOD, PharmacoEconomics, 10(2), 1996, pp. 152-163
Authors:
JANKNEGT R
VANETTEN EWM
DEMARIE S
Citation: R. Janknegt et al., LIPID FORMULATIONS OF AMPHOTERICIN-B, Current opinion in infectious diseases, 9(6), 1996, pp. 403-406
Authors:
JANKNEGT R
Citation: R. Janknegt, LIPOSOMAL FORMULATIONS OF CYTOTOXIC DRUGS, Supportive care in cancer, 4(4), 1996, pp. 298-304
Authors:
BONO AV
HALL RR
DENIS L
LOVISOLO JA
SYLVESTER R
HETHERINGTON J
SCHROEDER FH
KURTH KH
MARECHAL JM
BOUFFIOUX C
HOEKSTRA W
LANGENMEYER W
RUTISHAUSER G
JANKNEGT R
WHELAN P
CONSIDINE J
Citation: Av. Bono et al., CHEMORESECTION IN TA-T1 BLADDER-CANCER, European urology, 29(4), 1996, pp. 385-390
Authors:
STOBBERINGH E
JANKNEGT R
WIJNANDS WJA
Citation: E. Stobberingh et al., TREATMENT OF URINARY-TRACT INFECTIONS IN DUTCH HOSPITALS, Infection, 24(3), 1996, pp. 234-237
Authors:
SCHOLSHENDRIKS MWG
LOHMAN JJHM
JANKNEGT R
KORTEN JJ
MERKUS FWHM
HOOYMANS PM
Citation: Mwg. Scholshendriks et al., ABSORPTION OF CLONAZEPAM AFTER INTRANASAL AND BUCCAL ADMINISTRATION, British journal of clinical pharmacology, 39(4), 1995, pp. 449-451
Authors:
JANKNEGT R
Citation: R. Janknegt, FLUOROQUINOLONES - USE OF CLINICAL-DATA TO AID FORMULARY CHOICE BY THE SYSTEM OF OBJECTIVE JUDGMENT ANALYSIS (SOJA) METHOD, PharmacoEconomics, 6(1), 1994, pp. 15-33
Authors:
JANKNEGT R
WIJNANDS WJA
STOBBERINGH E
Citation: R. Janknegt et al., ANTIMICROBIAL PROPHYLAXIS IN BOWEL SURGERY IN THE NETHERLANDS, European journal of clinical microbiology & infectious diseases, 13(7), 1994, pp. 596-600
Authors:
JANKNEGT R
HOOYMANS PM
FABIUS GTJ
NOHLMANSPAULSSEN MKE
MACHIELSEN C
BOOGAARDVANDENBORN J
RANG J
SMITS CAM
WILLEMSTHISSEN ME
KROMMENHOEK A
Citation: R. Janknegt et al., URINARY CONCENTRATIONS OF FOSFOMYCIN AFTER A SINGLE 3G DOSE OF FOSFOMYCIN TO ELDERLY NURSING-HOME PATIENTS, Pharmacy world & science, 16(3), 1994, pp. 149-153
Authors:
JANKNEGT R
MONKELBAAN JF
STOBBERINGH E
WIJNANDS WJA
Citation: R. Janknegt et al., ANTIBIOTIC POLICIES IN DUTCH HOSPITALS FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTION, Journal of antimicrobial chemotherapy, 34(6), 1994, pp. 1059-1069
Authors:
JANKNEGT R
WIJNANDS WJA
STOBBERINGH EE
Citation: R. Janknegt et al., ANTIBIOTIC POLICIES IN DUTCH HOSPITALS FOR THE TREATMENT OF PNEUMONIA, Journal of antimicrobial chemotherapy, 34(3), 1994, pp. 431-442
Authors:
DEMARIE S
JANKNEGT R
BAKKERWOUDENBERG IAJM
Citation: S. Demarie et al., CLINICAL USE OF LIPOSOMAL AND LIPID-COMPLEXED AMPHOTERICIN-B, Journal of antimicrobial chemotherapy, 33(5), 1994, pp. 907-916
Authors:
JANKNEGT R
VANDERMEER JWM
Citation: R. Janknegt et Jwm. Vandermeer, ANTIMICROBIAL PRACTICE - SEQUENTIAL THERAPY WITH INTRAVENOUS AND ORALCEPHALOSPORINS, Journal of antimicrobial chemotherapy, 33(1), 1994, pp. 169-177
Authors:
JANKNEGT R
WIJNANDS WJA
CAPRASSE M
BRANDENBURG W
SCHUITENMAKER MG
STOBBERINGH E
Citation: R. Janknegt et al., ANTIMICROBIAL DRUG-USE IN HOSPITALS IN THE NETHERLANDS, GERMANY AND BELGIUM, European journal of clinical microbiology & infectious diseases, 12(11), 1993, pp. 832-838
Authors:
JANKNEGT R
Citation: R. Janknegt, AMINOGLYCOSIDE MONITORING IN THE ONCE-DAILY OR TWICE-DAILY ERA - THE DUTCH SITUATION CONSIDERED, Pharmacy world & science, 15(4), 1993, pp. 151-155
Authors:
STOBBERINGH E
JANKNEGT R
WIJNANDS G
Citation: E. Stobberingh et al., ANTIBIOTIC GUIDELINES AND ANTIBIOTIC UTILIZATION IN DUTCH HOSPITALS, Journal of antimicrobial chemotherapy, 32(1), 1993, pp. 153-161
Authors:
JANKNEGT R
SCHEPERS JP
HAEST JWG
FABIUS GTJ
LOHMAN JJHM
SMEETS AP
Citation: R. Janknegt et al., ANTIMICROBIAL PROPHYLAXIS IN HYSTERECTOMIES - A DOUBLE-BLIND, RANDOMIZED, COMPARATIVE-STUDY OF A SINGLE-DOSE OF PIPERACILLIN (2 G) VERSUS ASINGLE-DOSE OF AMOXICILLIN-CLAVULANIC ACID (2.2 G), Infection, 21(4), 1993, pp. 214-219
Authors:
KUIJPERS PMJC
JANKNEGT R
MOERS AMJ
HOOYMANS PM
BAS BM
Citation: Pmjc. Kuijpers et al., NO ACUTE TOXICITY AFTER MASSIVE ANTICOAGULANT OVERDOSE, Netherlands journal of medicine, 43(1-2), 1993, pp. 92-93
Risultati:
1-22
|